| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.42e-11 | 18 | 170 | 7 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.92e-09 | 28 | 170 | 7 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.38e-08 | 37 | 170 | 7 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH3 MYO7B DNAH2 DNAH7 DNAH14 DNAH1 MYH14 DNAH6 DNAH8 DYNC1H1 | 6.78e-08 | 118 | 170 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.19e-06 | 70 | 170 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 MYO7B ATP13A1 DDX60 DNAH2 PSMC5 DNAH7 DNAH14 DNAH1 DDX11 ABCG1 MYH14 DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 5.29e-06 | 614 | 170 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 ATP13A1 DDX60 DNAH2 PSMC5 DNAH7 DDX11 ABCG1 DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 2.60e-05 | 441 | 170 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 ATP13A1 DDX60 DNAH2 PSMC5 TUBB2B DNAH7 TUBB2A DDX11 TUBB6 ABCG1 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 1.13e-04 | 775 | 170 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.69e-04 | 37 | 170 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.99e-04 | 38 | 170 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 ATP13A1 DDX60 DNAH2 PSMC5 TUBB2B DNAH7 TUBB2A DDX11 TUBB6 ABCG1 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 2.99e-04 | 839 | 170 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 ATP13A1 DDX60 DNAH2 PSMC5 TUBB2B DNAH7 TUBB2A DDX11 TUBB6 ABCG1 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 3.03e-04 | 840 | 170 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 ATP13A1 DDX60 DNAH2 PSMC5 TUBB2B DNAH7 TUBB2A DDX11 TUBB6 ABCG1 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 XRCC6 | 3.03e-04 | 840 | 170 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.78e-04 | 17 | 170 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.78e-04 | 17 | 170 | 3 | GO:0019198 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | MYCBP2 CYP19A1 SLC26A5 DOCK10 RDX TUBB2B SEMA3G ITGA2 ACVR1C MSTN ONECUT1 CHRM1 PTPRT PGR LRIG2 JAK2 FAT1 PIK3C2A EGR1 PTPRR MTOR PTPRZ1 DOCK7 NINJ1 MAP3K7 NDRG4 EPHA1 EPHA3 | 3.19e-06 | 1327 | 168 | 28 | GO:0040012 |
| GeneOntologyBiologicalProcess | response to thyroid hormone | 2.28e-05 | 21 | 168 | 4 | GO:0097066 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | PSAP MYO7B SLC26A5 ITGA2 LRIG2 MYH14 SCN9A DIAPH3 USH2A TBX1 | 2.65e-05 | 238 | 168 | 10 | GO:0050954 |
| GeneOntologyBiologicalProcess | intracellular transport | EZR NUP50 RANBP2 GBF1 PSAP RGPD8 VPS13C XPO4 RDX COPG2 SNX33 LCP1 CHRM1 ARCN1 EPG5 JAK2 STK11 ABCG1 PIK3C3 STRADA VPS13A DOCK7 RAB7B DIAPH3 DDX39A NDRG4 DYNC1H1 RGPD5 | 2.93e-05 | 1496 | 168 | 28 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of cell motility | CYP19A1 SLC26A5 DOCK10 RDX SEMA3G ITGA2 ACVR1C MSTN ONECUT1 PTPRT PGR LRIG2 JAK2 FAT1 PIK3C2A EGR1 PTPRR MTOR PTPRZ1 DOCK7 NINJ1 MAP3K7 NDRG4 EPHA1 EPHA3 | 4.17e-05 | 1280 | 168 | 25 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of cell migration | CYP19A1 DOCK10 RDX SEMA3G ITGA2 ACVR1C MSTN ONECUT1 PTPRT PGR LRIG2 JAK2 FAT1 PIK3C2A EGR1 PTPRR MTOR PTPRZ1 DOCK7 NINJ1 MAP3K7 NDRG4 EPHA1 EPHA3 | 4.80e-05 | 1211 | 168 | 24 | GO:0030334 |
| GeneOntologyBiologicalProcess | organelle assembly | ATMIN EZR RPGRIP1 MYH3 GBF1 KIAA0586 DNAH2 BBIP1 RDX LCP1 ONECUT1 DNAH7 DNAH1 PIK3C3 MTOR FAM161A DOCK7 RAB7B DIAPH3 DNAH8 DYNC1H1 WNK3 KNL1 | 5.21e-05 | 1138 | 168 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | muscle cell migration | 5.35e-05 | 161 | 168 | 8 | GO:0014812 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell migration | 6.00e-05 | 83 | 168 | 6 | GO:0014911 | |
| GeneOntologyBiologicalProcess | establishment of monopolar cell polarity | 7.46e-05 | 28 | 168 | 4 | GO:0061162 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of monopolar cell polarity | 8.60e-05 | 29 | 168 | 4 | GO:0061339 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.04e-04 | 177 | 168 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 1.16e-04 | 134 | 168 | 7 | GO:0014910 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | CDHR1 CYP19A1 DOCK10 BBIP1 ACVR1C SH2B2 EPG5 SFXN1 JAK2 STK11 BMP8B EGR1 VPS13A DOCK7 KMT2A DIAPH3 USH2A MUC5AC DYNC1H1 WNK3 TJP3 | 1.19e-04 | 1043 | 168 | 21 | GO:0048871 |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 1.89e-04 | 145 | 168 | 7 | GO:0014909 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.25e-04 | 198 | 168 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | anoikis | 2.27e-04 | 37 | 168 | 4 | GO:0043276 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | EZR RANBP2 VPS13C LARS1 ITGA2 ACVR1C MSTN CHRM1 SH2B2 PGR EPG5 ITPR2 DDX11 JAK2 STK11 FAT1 PIK3C2A EGR1 TMEM259 MTOR HES1 GRIN3B MAP3K7 | 2.70e-04 | 1272 | 168 | 23 | GO:1901698 |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | SLC26A5 RDX SEMA3G ITGA2 MSTN ONECUT1 PGR JAK2 FAT1 PIK3C2A EGR1 MTOR PTPRZ1 DOCK7 MAP3K7 EPHA1 | 2.97e-04 | 725 | 168 | 16 | GO:2000147 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | EZR MYCBP2 PSMC5 RDX SNX33 ITGA2 ACVR1C YES1 PAIP1 JAK2 STK11 USP5 ABCG1 EGR1 TMEM259 MTOR PTPRZ1 FAM161A STRADA DOCK7 HES1 MAP3K7 XRCC6 WNK3 TBX1 | 3.21e-04 | 1458 | 168 | 25 | GO:0051247 |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 3.24e-04 | 73 | 168 | 5 | GO:0050879 | |
| GeneOntologyBiologicalProcess | response to hormone | VPS13C SLC26A5 RDX ITGA2 ACVR1C MSTN SH2B2 PGR JAK2 TGIF1 STK11 FAT1 PIK3C2A EGR1 MTOR PRMT2 HES1 MAP3K7 TBX1 EPHA3 | 3.27e-04 | 1042 | 168 | 20 | GO:0009725 |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 3.32e-04 | 17 | 168 | 3 | GO:0036159 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 3.40e-04 | 41 | 168 | 4 | GO:0070286 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | EZR GBF1 MYCBP2 KIAA0586 XPO4 RDX SNX33 ACVR1C LCP1 CHRM1 LRIG2 JAK2 STK11 ABCG1 MTOR MEPCE DCLK3 NDRG4 DYNC1H1 WNK3 EPB41L1 EPHA3 | 3.51e-04 | 1212 | 168 | 22 | GO:0060341 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 3.71e-04 | 162 | 168 | 7 | GO:0032388 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | NUP50 RANBP2 PSAP RGPD8 VPS13C XPO4 COPG2 SNX33 LCP1 CHRM1 ARCN1 JAK2 PIK3C3 STRADA VPS13A RGPD5 | 3.72e-04 | 740 | 168 | 16 | GO:0006886 |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SLC26A5 RDX SEMA3G ITGA2 MSTN ONECUT1 PGR JAK2 FAT1 PIK3C2A EGR1 MTOR PTPRZ1 DOCK7 MAP3K7 EPHA1 | 3.83e-04 | 742 | 168 | 16 | GO:0040017 |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 3.96e-04 | 18 | 168 | 3 | GO:0006895 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ATMIN EZR RPGRIP1 GBF1 KIAA0586 DNAH2 BBIP1 RDX MSTN ONECUT1 DNAH7 DNAH1 MTOR FAM161A DNAH8 | 3.96e-04 | 670 | 168 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | microtubule-based process | EZR DNAH2 COPG2 TUBB2B DNAH7 TUBB2A DNAH14 DNAH1 TUBB6 STK11 CCSER2 VPS13A DOCK7 CDK11B DIAPH3 DNAH6 DNAH8 DYNC1H1 EPHA3 SON | 3.97e-04 | 1058 | 168 | 20 | GO:0007017 |
| GeneOntologyCellularComponent | dynein complex | 2.67e-07 | 54 | 170 | 7 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 8.53e-07 | 10 | 170 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.56e-06 | 25 | 170 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | filopodium | 6.69e-05 | 123 | 170 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | supramolecular fiber | EZR MYH3 DNAH2 TUBB2B LCP1 YES1 DNAH7 SH2B2 TUBB2A DNAH14 DNAH1 TUBB6 STK11 MYH14 FAM161A AHNAK SPHKAP DIAPH2 DIAPH3 DNAH6 DNAH8 DYNC1H1 AHNAK2 | 8.75e-05 | 1179 | 170 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EZR MYH3 DNAH2 TUBB2B LCP1 YES1 DNAH7 SH2B2 TUBB2A DNAH14 DNAH1 TUBB6 STK11 MYH14 FAM161A AHNAK SPHKAP DIAPH2 DIAPH3 DNAH6 DNAH8 DYNC1H1 AHNAK2 | 9.68e-05 | 1187 | 170 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.55e-04 | 161 | 170 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | T-tubule | 4.65e-04 | 79 | 170 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.68e-04 | 278 | 170 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | inclusion body | 8.44e-04 | 90 | 170 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | actin cytoskeleton | EZR MYH3 MYO7B RDX LCP1 YES1 SH2B2 MYH14 AHNAK DIAPH2 DIAPH3 HSPB7 EPHA3 | 8.90e-04 | 576 | 170 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EZR DNAH2 TUBB2B LCP1 YES1 DNAH7 SH2B2 TUBB2A DNAH14 DNAH1 TUBB6 FAM161A DIAPH2 DIAPH3 DNAH6 DNAH8 DYNC1H1 | 1.08e-03 | 899 | 170 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | actin filament | 1.26e-03 | 146 | 170 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | nuclear pore | 1.42e-03 | 101 | 170 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | axoneme | 1.56e-03 | 207 | 170 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.60e-03 | 208 | 170 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.73e-03 | 335 | 170 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.78e-03 | 8 | 170 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.78e-03 | 8 | 170 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.82e-03 | 157 | 170 | 6 | GO:1902554 | |
| MousePheno | increased organ/body region tumor incidence | RANBP2 RGPD8 POLE E2F1 PTPRT JAK2 STK11 EGR1 MYH14 PTPRZ1 KMT2A CDK11B XRCC6 TP53BP1 | 2.58e-05 | 395 | 134 | 14 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | RANBP2 RGPD8 POLE E2F1 PTPRT JAK2 STK11 EGR1 MYH14 PTPRZ1 KMT2A CDK11B XRCC6 TP53BP1 | 3.05e-05 | 401 | 134 | 14 | MP:0013152 |
| Domain | Dynein_heavy_chain_D4_dom | 1.26e-11 | 14 | 166 | 7 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.26e-11 | 14 | 166 | 7 | IPR024743 | |
| Domain | MT | 1.26e-11 | 14 | 166 | 7 | PF12777 | |
| Domain | AAA_8 | 1.26e-11 | 14 | 166 | 7 | PF12780 | |
| Domain | DHC_fam | 2.34e-11 | 15 | 166 | 7 | IPR026983 | |
| Domain | Dynein_heavy | 2.34e-11 | 15 | 166 | 7 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.34e-11 | 15 | 166 | 7 | IPR004273 | |
| Domain | Dynein_heavy_dom-2 | 1.27e-09 | 14 | 166 | 6 | IPR013602 | |
| Domain | DHC_N2 | 1.27e-09 | 14 | 166 | 6 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 9.80e-08 | 14 | 166 | 5 | IPR011704 | |
| Domain | AAA_5 | 9.80e-08 | 14 | 166 | 5 | PF07728 | |
| Domain | Ran_BP1 | 2.82e-06 | 12 | 166 | 4 | PF00638 | |
| Domain | RANBD1 | 2.82e-06 | 12 | 166 | 4 | PS50196 | |
| Domain | RanBD | 4.04e-06 | 13 | 166 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 4.04e-06 | 13 | 166 | 4 | IPR000156 | |
| Domain | DHC_N1 | 3.74e-05 | 8 | 166 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.74e-05 | 8 | 166 | 3 | IPR013594 | |
| Domain | AAA | 4.44e-05 | 144 | 166 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 4.44e-05 | 144 | 166 | 8 | IPR003593 | |
| Domain | FERM_central | 7.26e-05 | 49 | 166 | 5 | IPR019748 | |
| Domain | FERM_domain | 7.26e-05 | 49 | 166 | 5 | IPR000299 | |
| Domain | CSTF2_hinge | 7.85e-05 | 2 | 166 | 2 | PF14327 | |
| Domain | CSTF_C | 7.85e-05 | 2 | 166 | 2 | PF14304 | |
| Domain | CSTF2_hinge | 7.85e-05 | 2 | 166 | 2 | IPR025742 | |
| Domain | CSTF_C | 7.85e-05 | 2 | 166 | 2 | IPR026896 | |
| Domain | Beta-tubulin_BS | 7.90e-05 | 10 | 166 | 3 | IPR013838 | |
| Domain | Beta_tubulin | 7.90e-05 | 10 | 166 | 3 | IPR002453 | |
| Domain | FERM_1 | 8.01e-05 | 50 | 166 | 5 | PS00660 | |
| Domain | FERM_2 | 8.01e-05 | 50 | 166 | 5 | PS00661 | |
| Domain | FERM_3 | 8.01e-05 | 50 | 166 | 5 | PS50057 | |
| Domain | Band_41_domain | 8.01e-05 | 50 | 166 | 5 | IPR019749 | |
| Domain | B41 | 8.01e-05 | 50 | 166 | 5 | SM00295 | |
| Domain | TUBULIN_B_AUTOREG | 1.08e-04 | 11 | 166 | 3 | PS00228 | |
| Domain | P-loop_NTPase | MYH3 MYO7B DDX60 DNAH2 PSMC5 DNAH7 DNAH14 DNAH1 SULT1E1 DDX11 ABCG1 MYH14 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 TJP3 | 1.98e-04 | 848 | 166 | 19 | IPR027417 |
| Domain | Drf_DAD | 2.34e-04 | 3 | 166 | 2 | PF06345 | |
| Domain | VPS13 | 2.34e-04 | 3 | 166 | 2 | IPR026847 | |
| Domain | Drf_DAD | 2.34e-04 | 3 | 166 | 2 | IPR010465 | |
| Domain | VPS13_mid_rpt | 2.34e-04 | 3 | 166 | 2 | PF16910 | |
| Domain | VPS13 | 2.34e-04 | 3 | 166 | 2 | PF16908 | |
| Domain | VPS13_N2 | 2.34e-04 | 3 | 166 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 2.34e-04 | 3 | 166 | 2 | IPR031642 | |
| Domain | PI3/4_kinase_CS | 2.90e-04 | 15 | 166 | 3 | IPR018936 | |
| Domain | Kinase-like_dom | ACVR1C YES1 JAK2 STK11 PIK3C2A PIK3C3 MTOR STRADA DCLK3 CDK11B MAP3K7 WNK3 EPHA1 EPHA3 | 3.54e-04 | 542 | 166 | 14 | IPR011009 |
| Domain | - | 3.55e-04 | 16 | 166 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.55e-04 | 16 | 166 | 3 | SM00146 | |
| Domain | - | MYO7B DDX60 DNAH2 PSMC5 DNAH7 DNAH14 DNAH1 SULT1E1 DDX11 ABCG1 RAB7B DDX39A DNAH6 DNAH8 SNRNP200 DYNC1H1 TJP3 | 3.59e-04 | 746 | 166 | 17 | 3.40.50.300 |
| Domain | ERM_C_dom | 4.66e-04 | 4 | 166 | 2 | IPR011259 | |
| Domain | SHR-BD | 4.66e-04 | 4 | 166 | 2 | IPR009543 | |
| Domain | VPS13_C | 4.66e-04 | 4 | 166 | 2 | PF16909 | |
| Domain | ERM | 4.66e-04 | 4 | 166 | 2 | PF00769 | |
| Domain | VPS13_C | 4.66e-04 | 4 | 166 | 2 | IPR031645 | |
| Domain | SHR-BD | 4.66e-04 | 4 | 166 | 2 | PF06650 | |
| Domain | ERM | 4.66e-04 | 4 | 166 | 2 | IPR011174 | |
| Domain | PI3_PI4_kinase | 5.10e-04 | 18 | 166 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.10e-04 | 18 | 166 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.10e-04 | 18 | 166 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.10e-04 | 18 | 166 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.10e-04 | 18 | 166 | 3 | PS50290 | |
| Domain | - | 7.03e-04 | 20 | 166 | 3 | 3.30.1330.20 | |
| Domain | FERM_M | 7.34e-04 | 46 | 166 | 4 | PF00373 | |
| Domain | Autophagy-rel_C | 7.72e-04 | 5 | 166 | 2 | IPR015412 | |
| Domain | ATG_C | 7.72e-04 | 5 | 166 | 2 | PF09333 | |
| Domain | - | 8.15e-04 | 21 | 166 | 3 | 1.10.287.600 | |
| Domain | Ez/rad/moesin-like | 8.15e-04 | 21 | 166 | 3 | IPR000798 | |
| Domain | ARM-type_fold | GBF1 XPO4 COPG2 PAIP1 ITPR2 PIK3C2A PIK3C3 MTOR DIAPH2 DIAPH3 | 9.29e-04 | 339 | 166 | 10 | IPR016024 |
| Domain | - | 9.34e-04 | 49 | 166 | 4 | 1.20.80.10 | |
| Domain | Tubulin_C | 9.38e-04 | 22 | 166 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 9.38e-04 | 22 | 166 | 3 | IPR018316 | |
| Domain | - | 9.38e-04 | 22 | 166 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 9.38e-04 | 22 | 166 | 3 | SM00865 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.01e-03 | 50 | 166 | 4 | IPR014352 | |
| Domain | Pkinase_Tyr | 1.04e-03 | 129 | 166 | 6 | PF07714 | |
| Domain | Tub_FtsZ_C | 1.07e-03 | 23 | 166 | 3 | IPR008280 | |
| Domain | Tubulin_C | 1.07e-03 | 23 | 166 | 3 | IPR023123 | |
| Domain | TUBULIN | 1.07e-03 | 23 | 166 | 3 | PS00227 | |
| Domain | Tubulin | 1.07e-03 | 23 | 166 | 3 | IPR000217 | |
| Domain | Tubulin | 1.07e-03 | 23 | 166 | 3 | SM00864 | |
| Domain | Tubulin_CS | 1.07e-03 | 23 | 166 | 3 | IPR017975 | |
| Domain | DUF3398 | 1.15e-03 | 6 | 166 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.15e-03 | 6 | 166 | 2 | IPR021816 | |
| Domain | Tubulin_FtsZ_GTPase | 1.22e-03 | 24 | 166 | 3 | IPR003008 | |
| Domain | FERM_CS | 1.22e-03 | 24 | 166 | 3 | IPR019747 | |
| Domain | Tubulin | 1.22e-03 | 24 | 166 | 3 | PF00091 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.47e-03 | 138 | 166 | 6 | IPR001245 | |
| Domain | PH_dom-like | EZR NUP50 RANBP2 RGPD8 MYO7B DOCK10 RDX SH2B2 JAK2 EPB41L1 RGPD5 | 1.53e-03 | 426 | 166 | 11 | IPR011993 |
| Domain | FERM_C | 1.54e-03 | 26 | 166 | 3 | PF09380 | |
| Domain | Moesin_tail | 1.60e-03 | 7 | 166 | 2 | IPR008954 | |
| Domain | FERM_PH-like_C | 1.72e-03 | 27 | 166 | 3 | IPR018980 | |
| Domain | FERM_C | 1.72e-03 | 27 | 166 | 3 | SM01196 | |
| Domain | - | 2.10e-03 | 148 | 166 | 6 | 2.60.40.150 | |
| Domain | DAD_dom | 2.12e-03 | 8 | 166 | 2 | IPR014767 | |
| Domain | Chorein_N | 2.12e-03 | 8 | 166 | 2 | PF12624 | |
| Domain | DAD | 2.12e-03 | 8 | 166 | 2 | PS51231 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 2.12e-03 | 8 | 166 | 2 | IPR002420 | |
| Domain | VPS13_N | 2.12e-03 | 8 | 166 | 2 | IPR026854 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | PF00792 | |
| Domain | PI3K_C2 | 2.12e-03 | 8 | 166 | 2 | PS51547 | |
| Domain | PI3Ka | 2.71e-03 | 9 | 166 | 2 | PF00613 | |
| Domain | Drf_GBD | 2.71e-03 | 9 | 166 | 2 | PF06371 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.95e-09 | 43 | 131 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.24e-09 | 45 | 131 | 8 | M47670 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.40e-06 | 27 | 131 | 5 | M47755 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.20e-05 | 37 | 131 | 5 | MM15102 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 2.48e-05 | 19 | 131 | 4 | M22005 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 4.52e-05 | 102 | 131 | 7 | M27648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 4.65e-05 | 43 | 131 | 5 | M47773 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.80e-05 | 140 | 131 | 8 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.05e-05 | 141 | 131 | 8 | MM15266 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 7.33e-05 | 110 | 131 | 7 | MM15350 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.82e-05 | 49 | 131 | 5 | M891 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.03e-04 | 116 | 131 | 7 | MM15715 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.18e-04 | 52 | 131 | 5 | MM14949 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.34e-04 | 121 | 131 | 7 | M872 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.41e-04 | 29 | 131 | 4 | M27309 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | RANBP2 RGPD8 TUBB2B TUBB2A TUBB6 PIK3C3 MYH14 DIAPH2 DIAPH3 DYNC1H1 | 1.42e-04 | 257 | 131 | 10 | MM14755 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.82e-04 | 57 | 131 | 5 | M27251 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.19e-04 | 131 | 131 | 7 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.51e-04 | 134 | 131 | 7 | M27751 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.00e-04 | 98 | 131 | 6 | MM15352 | |
| Pathway | REACTOME_AGGREPHAGY | 3.33e-04 | 36 | 131 | 4 | MM15669 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.35e-04 | 100 | 131 | 6 | M27650 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.19e-04 | 68 | 131 | 5 | MM14968 | |
| Pathway | WP_OVARIAN_INFERTILITY | 4.55e-04 | 39 | 131 | 4 | M39458 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.85e-04 | 17 | 131 | 3 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.85e-04 | 17 | 131 | 3 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.78e-04 | 18 | 131 | 3 | M47753 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 6.30e-04 | 156 | 131 | 7 | M27097 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.82e-04 | 19 | 131 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.82e-04 | 19 | 131 | 3 | M47813 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.25e-04 | 44 | 131 | 4 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 7.25e-04 | 44 | 131 | 4 | M29830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 7.96e-04 | 20 | 131 | 3 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 7.96e-04 | 20 | 131 | 3 | M47911 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | RANBP2 TUBB2B TUBB2A TUBB6 PIK3C3 MYH14 DIAPH2 DIAPH3 DYNC1H1 KNL1 | 8.65e-04 | 323 | 131 | 10 | M27080 |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 9.23e-04 | 21 | 131 | 3 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 9.23e-04 | 21 | 131 | 3 | M47767 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 9.32e-04 | 47 | 131 | 4 | M39518 | |
| Pathway | PID_LKB1_PATHWAY | 9.32e-04 | 47 | 131 | 4 | M87 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 9.75e-04 | 168 | 131 | 7 | MM14785 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.01e-03 | 48 | 131 | 4 | MM15353 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.05e-03 | 170 | 131 | 7 | M941 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.06e-03 | 22 | 131 | 3 | M47903 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.19e-03 | 127 | 131 | 6 | M27181 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.21e-03 | 23 | 131 | 3 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION | 1.21e-03 | 23 | 131 | 3 | M47772 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.21e-03 | 23 | 131 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.21e-03 | 23 | 131 | 3 | M47900 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.28e-03 | 129 | 131 | 6 | MM14894 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.34e-03 | 130 | 131 | 6 | MM14627 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.38e-03 | 24 | 131 | 3 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.38e-03 | 24 | 131 | 3 | M47700 | |
| Pubmed | 4.03e-11 | 14 | 173 | 6 | 9373155 | ||
| Pubmed | EZR RPGRIP1 MYH3 RANBP2 RGPD8 PPFIA4 DNAH2 RDX LCP1 NDUFV2 DDX11 STK11 MYH14 FAM161A AHNAK VPS13A SCN9A ANKRD30A KMT2A DLEC1 DIAPH3 DDX39A DNAH6 DNAH8 XRCC6 TBX1 RGPD5 | 3.17e-09 | 1442 | 173 | 27 | 35575683 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EZR RANBP2 GBF1 PSAP MYCBP2 LARS1 PSMC5 RDX COPG2 TUBB2B LCP1 TUBB2A ARCN1 SCAF4 TUBB6 USP5 AHNAK DOCK7 CSTF2 PATJ MAP3K7 SNRNP200 DYNC1H1 XRCC6 | 3.24e-09 | 1149 | 173 | 24 | 35446349 |
| Pubmed | PSMC5 TUBB2B TUBB2A ARCN1 SFXN1 TUBB6 R3HCC1L MYH14 CSTF2 DDX39A | 1.22e-08 | 166 | 173 | 10 | 34687317 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EZR MYCBP2 LARS1 COPG2 TUBB2A ARCN1 EPG5 DNAH1 SFXN1 TUBB6 USP5 MYH14 AHNAK KMT2A DDX39A SNRNP200 DYNC1H1 XRCC6 AHNAK2 | 2.48e-08 | 807 | 173 | 19 | 30575818 |
| Pubmed | RANBP2 MYCBP2 POLE PSMC5 COPG2 LCP1 USP5 MYH14 MTOR AHNAK DOCK7 KMT2A SNRNP200 DYNC1H1 XRCC6 TP53BP1 SON | 3.36e-08 | 653 | 173 | 17 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 RANBP2 ZNF280C LARS1 PSMC5 RDX COPG2 SNX29 ARCN1 SCAF4 R3HCC1L AHNAK MEPCE KMT2A SNRNP200 XRCC6 TP53BP1 KNL1 SON AHNAK2 | 4.93e-08 | 934 | 173 | 20 | 33916271 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | GBF1 DDX60 LRRC31 MYH14 MTOR AHNAK DOCK7 ANKRD30A SNRNP200 XRCC6 | 7.81e-08 | 202 | 173 | 10 | 33005030 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 POLE LARS1 PSMC5 COPG2 TUBB2B YES1 ARCN1 SFXN1 TUBB6 MTOR DDX39A DNAH8 SNRNP200 DYNC1H1 TP53BP1 SON | 9.86e-08 | 704 | 173 | 17 | 29955894 |
| Pubmed | EZR MYCBP2 ARCN1 SCAF4 AHNAK DOCK7 CSTF2 KMT2A DIAPH3 PATJ SNRNP200 DYNC1H1 CSTF2T TP53BP1 RGPD5 | 1.21e-07 | 549 | 173 | 15 | 38280479 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EZR RANBP2 LARS1 PSMC5 TUBB6 USP5 AHNAK DDX39A SNRNP200 DYNC1H1 TP53BP1 AHNAK2 | 1.21e-07 | 332 | 173 | 12 | 32786267 |
| Pubmed | 1.26e-07 | 47 | 173 | 6 | 8812413 | ||
| Pubmed | LARS1 PSMC5 TUBB2B TUBB2A ARCN1 MYH14 DOCK7 PATJ DDX39A SNRNP200 DYNC1H1 XRCC6 | 1.29e-07 | 334 | 173 | 12 | 30425250 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EZR MYH3 RANBP2 XPO4 PSMC5 RDX COPG2 ITGA2 ARCN1 SFXN1 TUBB6 MYH14 MTOR AHNAK DYNC1H1 TP53BP1 | 1.74e-07 | 647 | 173 | 16 | 26618866 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH3 VPS13C DNAH2 DNAH14 ARCN1 ITPR2 SFXN1 JAK2 FREM2 R3HCC1L SYDE2 AHNAK VPS13A CSTF2 SNRNP200 DYNC1H1 XRCC6 | 1.85e-07 | 736 | 173 | 17 | 29676528 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EZR RANBP2 MYCBP2 LARS1 PSMC5 TUBB2B YES1 ARCN1 SCAF4 ITPR2 SFXN1 TUBB6 MYH14 AHNAK DOCK7 CSTF2 SNRNP200 DYNC1H1 XRCC6 SON | 2.15e-07 | 1024 | 173 | 20 | 24711643 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | RANBP2 ATP13A1 LARS1 PSMC5 TUBB2B COLGALT1 PAIP1 SFXN1 AHNAK CDK11B DYNC1H1 XRCC6 AHNAK2 | 2.24e-07 | 422 | 173 | 13 | 27342126 |
| Pubmed | RANBP2 DDX60 LARS1 XPO4 PSMC5 COPG2 TUBB2B COLGALT1 YES1 TUBB2A ARCN1 ITPR2 TUBB6 USP5 PIK3C2A TMEM259 MTOR AHNAK DOCK7 KMT2A SNRNP200 DYNC1H1 XRCC6 AHNAK2 | 2.24e-07 | 1440 | 173 | 24 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EZR NUP50 GBF1 PSAP GON7 LARS1 PSMC5 RDX PAIP1 TUBB2A ARCN1 TUBB6 USP5 MYH14 MTOR AHNAK MEPCE CSTF2 DDX39A SNRNP200 DYNC1H1 XRCC6 EPB41L1 AHNAK2 | 2.70e-07 | 1455 | 173 | 24 | 22863883 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 MYCBP2 POLE LARS1 DOCK10 PSMC5 TUBB2B SNX33 COLGALT1 ARCN1 SFXN1 TUBB6 USP5 PIK3C2A MYH14 AHNAK DDX39A SNRNP200 DYNC1H1 XRCC6 TP53BP1 SON AHNAK2 | 2.91e-07 | 1353 | 173 | 23 | 29467282 |
| Pubmed | NUP50 RANBP2 MYCBP2 ZNF280C XPO4 PSMC5 COPG2 COLGALT1 TUBB2A PTPRT ITPR2 TUBB6 PTPRR PTPRZ1 AHNAK VPS13A CSTF2 MAP3K7 EPB41L1 KNL1 | 3.15e-07 | 1049 | 173 | 20 | 27880917 | |
| Pubmed | EZR RANBP2 RGPD8 MYCBP2 RDX TUBB2B LRIG2 TUBB6 TMEM259 MTOR SPHKAP DOCK7 DIAPH2 SLC4A4 DYNC1H1 XRCC6 WNK3 EPB41L1 TP53BP1 | 3.79e-07 | 963 | 173 | 19 | 28671696 | |
| Pubmed | 4.82e-07 | 4 | 173 | 3 | 9480752 | ||
| Pubmed | EZR RANBP2 LARS1 PSMC5 RDX COPG2 ARCN1 AHNAK DOCK7 DIAPH3 PATJ SNRNP200 DYNC1H1 XRCC6 EPB41L1 EPHA3 | 5.75e-07 | 708 | 173 | 16 | 39231216 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN CRYBG2 GBF1 MYCBP2 ATP13A1 POLE EMID1 SH2B2 ITPR2 JAK2 BMP8B FAT1 TMEM259 MTOR AHNAK DIAPH2 TAGLN DYNC1H1 AHNAK2 TJP3 | 7.08e-07 | 1105 | 173 | 20 | 35748872 |
| Pubmed | MYH3 PSMC5 COLGALT1 MSTN ARCN1 AHNAK DOCK7 MAP3K7 SNRNP200 AHNAK2 | 7.73e-07 | 259 | 173 | 10 | 31162944 | |
| Pubmed | EZR RANBP2 LARS1 PSMC5 COPG2 PAIP1 TUBB6 AHNAK DDX39A SNRNP200 XRCC6 | 9.13e-07 | 330 | 173 | 11 | 32529326 | |
| Pubmed | 9.45e-07 | 104 | 173 | 7 | 36055981 | ||
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 39056782 | ||
| Pubmed | Mst4 and Ezrin induce brush borders downstream of the Lkb1/Strad/Mo25 polarization complex. | 1.20e-06 | 5 | 173 | 3 | 19386264 | |
| Pubmed | STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. | 1.20e-06 | 5 | 173 | 3 | 20424326 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.20e-06 | 5 | 173 | 3 | 12629516 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RANBP2 ATP13A1 POLE LARS1 DNAH2 PSMC5 COPG2 TUBB2A ARCN1 NDUFV2 SFXN1 USP5 TMEM259 MTOR CSTF2 MAP3K7 DYNC1H1 WNK3 | 1.23e-06 | 942 | 173 | 18 | 31073040 |
| Pubmed | 1.44e-06 | 215 | 173 | 9 | 35973513 | ||
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.52e-06 | 71 | 173 | 6 | 29346117 | |
| Pubmed | EZR NUP50 LARS1 PSMC5 LCP1 SCAF4 MEPCE DOCK7 CSTF2 SNRNP200 DYNC1H1 TP53BP1 SON | 1.71e-06 | 506 | 173 | 13 | 30890647 | |
| Pubmed | TDRKH VPS13C COPG2 DNAH7 TUBB2A ARCN1 SFXN1 LRIG2 FAT1 SYDE2 AHNAK VPS13A DOCK7 MAP3K7 SNRNP200 DYNC1H1 | 1.92e-06 | 777 | 173 | 16 | 35844135 | |
| Pubmed | 2.28e-06 | 76 | 173 | 6 | 27542412 | ||
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 22696681 | ||
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 19551860 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.69e-06 | 232 | 173 | 9 | 25515538 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.99e-06 | 235 | 173 | 9 | 30258100 | |
| Pubmed | EZR LARS1 PSMC5 PAIP1 ARCN1 MTOR AHNAK MEPCE CDK11B SNRNP200 DYNC1H1 XRCC6 AHNAK2 | 3.34e-06 | 538 | 173 | 13 | 28524877 | |
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 9256245 | ||
| Pubmed | RANBP2 LARS1 PSMC5 RDX COPG2 YES1 TUBB2A ARCN1 DNAH1 SFXN1 TUBB6 PIK3C2A MYH14 MEPCE PATJ DDX39A MAP3K7 DYNC1H1 XRCC6 TJP3 | 4.41e-06 | 1247 | 173 | 20 | 27684187 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EZR NUP50 RANBP2 GBF1 PSAP PSMC5 YES1 PAIP1 ARCN1 SFXN1 USP5 PIK3C2A MTOR AHNAK TAGLN DDX39A XRCC6 TP53BP1 KNL1 SON AHNAK2 | 4.86e-06 | 1367 | 173 | 21 | 32687490 |
| Pubmed | EZR RANBP2 RGPD8 COPG2 TUBB2B SNX33 TUBB2A ARCN1 TUBB6 MYH14 AHNAK MAP3K7 SNRNP200 DYNC1H1 XRCC6 RGPD5 | 5.48e-06 | 844 | 173 | 16 | 25963833 | |
| Pubmed | EZR RANBP2 LARS1 PSMC5 COPG2 TUBB2A TUBB6 AHNAK DOCK7 DYNC1H1 XRCC6 | 5.66e-06 | 399 | 173 | 11 | 37536630 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EZR LARS1 DNAH2 PSMC5 RDX LCP1 TUBB2A ARCN1 SCAF4 USP5 MYH14 DDX39A DNAH6 SNRNP200 DYNC1H1 XRCC6 | 5.73e-06 | 847 | 173 | 16 | 35235311 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NUP50 RANBP2 ZNF280C COPG2 TUBB2B TUBB2A NDUFV2 SCAF4 AHNAK CSTF2 KMT2A CDK11B SNRNP200 XRCC6 TP53BP1 KNL1 SON | 6.23e-06 | 954 | 173 | 17 | 36373674 |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 6.65e-06 | 8 | 173 | 3 | 23246003 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 MYCBP2 DNAH7 PIK3C2A PIK3C3 MTOR SYDE2 AHNAK CCSER2 MEPCE DOCK7 KMT2A PATJ WNK3 EPB41L1 AHNAK2 | 7.03e-06 | 861 | 173 | 16 | 36931259 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RPGRIP1 MAN2C1 PSAP PSMC5 COPG2 SCAF4 MYH14 MTOR MEPCE USH2A SNRNP200 DYNC1H1 XRCC6 TP53BP1 | 7.33e-06 | 670 | 173 | 14 | 22990118 |
| Pubmed | EZR MYH3 RANBP2 PSAP MYCBP2 RDX PIK3C2A MYH14 CIPC MAP3K7 XRCC6 SON | 8.09e-06 | 497 | 173 | 12 | 23414517 | |
| Pubmed | 8.17e-06 | 55 | 173 | 5 | 33067418 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ATP13A1 VPS13C LARS1 TUBB6 AHNAK DDX39A SNRNP200 DYNC1H1 AHNAK2 | 8.64e-06 | 268 | 173 | 9 | 33024031 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EZR NUP50 RANBP2 GBF1 ATP13A1 VPS13C POLE ZNF280C KIAA0586 LARS1 PSMC5 RDX COLGALT1 ARCN1 SFXN1 MYH14 MTOR DOCK7 SNRNP200 DYNC1H1 XRCC6 | 9.14e-06 | 1425 | 173 | 21 | 30948266 |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 9.49e-06 | 27 | 173 | 4 | 18649358 | |
| Pubmed | EZR NUP50 RANBP2 MYCBP2 LARS1 LCP1 SCAF4 TGIF1 EGR1 KMT2A ELF1 DDX39A SNRNP200 DYNC1H1 XRCC6 CSTF2T TP53BP1 KNL1 | 1.09e-05 | 1103 | 173 | 18 | 34189442 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | EZR RANBP2 RGPD8 LARS1 LCP1 ITPR2 SFXN1 USP5 MEPCE CSTF2 DDX39A CWF19L1 XRCC6 CSTF2T | 1.22e-05 | 701 | 173 | 14 | 30196744 |
| Pubmed | 1.26e-05 | 102 | 173 | 6 | 11214970 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | NUP50 RANBP2 PSMC5 TUBB2B TUBB2A TUBB6 USP5 CSTF2 SNRNP200 DYNC1H1 | 1.32e-05 | 357 | 173 | 10 | 37059091 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH3 PSAP VPS13C AOX1 PSMC5 RDX LCP1 TUBB2A TUBB6 STK11 FAT1 PIK3C2A MYH14 AHNAK SLC4A4 PATJ DYNC1H1 | 1.40e-05 | 1016 | 173 | 17 | 19056867 |
| Pubmed | Dynein and kinesin regulate stress-granule and P-body dynamics. | 1.41e-05 | 10 | 173 | 3 | 19825938 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RANBP2 RGPD8 COPG2 TUBB2B TUBB2A ITPR2 TUBB6 MYH14 AHNAK SNRNP200 DYNC1H1 XRCC6 RGPD5 | 1.67e-05 | 626 | 173 | 13 | 33644029 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RANBP2 GBF1 RGPD8 MYCBP2 POLE LARS1 PSMC5 TUBB2B TUBB2A ARCN1 DDX11 SFXN1 TUBB6 MAGED4 DDX39A SNRNP200 DYNC1H1 XRCC6 RGPD5 | 1.77e-05 | 1257 | 173 | 19 | 37317656 |
| Pubmed | LARS1 PSMC5 COPG2 TUBB2B LCP1 YES1 DNAH7 TUBB2A ARCN1 TUBB6 MYH14 MEPCE CSTF2 HES1 CDK11B SNRNP200 DYNC1H1 XRCC6 | 1.96e-05 | 1153 | 173 | 18 | 29845934 | |
| Pubmed | RANBP2 GBF1 LARS1 PSMC5 COPG2 ARCN1 TUBB6 USP5 MTOR SNRNP200 DYNC1H1 XRCC6 SON | 2.04e-05 | 638 | 173 | 13 | 33239621 | |
| Pubmed | EZR RANBP2 GBF1 MYCBP2 ATP13A1 DOCK10 PSMC5 COLGALT1 ARCN1 ITPR2 PIK3C2A PIK3C3 MYH14 MTOR AHNAK DDX39A DYNC1H1 XRCC6 | 2.32e-05 | 1168 | 173 | 18 | 19946888 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 2.35e-05 | 233 | 173 | 8 | 32290105 | |
| Pubmed | 2.44e-05 | 34 | 173 | 4 | 36572190 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 30093459 | ||
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 2.46e-05 | 2 | 173 | 2 | 12773396 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 32634329 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 24242166 | ||
| Pubmed | Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology. | 2.46e-05 | 2 | 173 | 2 | 31382374 | |
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 2.46e-05 | 2 | 173 | 2 | 12618768 | |
| Pubmed | Primary cilia regulate mTORC1 activity and cell size through Lkb1. | 2.46e-05 | 2 | 173 | 2 | 20972424 | |
| Pubmed | TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia. | 2.46e-05 | 2 | 173 | 2 | 25349154 | |
| Pubmed | Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men. | 2.46e-05 | 2 | 173 | 2 | 19299575 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 31262977 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 25952930 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 21612657 | ||
| Pubmed | The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes. | 2.46e-05 | 2 | 173 | 2 | 21702994 | |
| Pubmed | SON DNA-binding protein mediates macrophage autophagy and responses to intracellular infection. | 2.46e-05 | 2 | 173 | 2 | 32484234 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17085580 | ||
| Pubmed | Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer. | 2.46e-05 | 2 | 173 | 2 | 17661084 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 28602698 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 36656016 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 14681198 | ||
| Pubmed | P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. | 2.46e-05 | 2 | 173 | 2 | 12646190 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 19276347 | ||
| Pubmed | Multimodal regulation of E2F1 gene expression by progestins. | 2.46e-05 | 2 | 173 | 2 | 20123965 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18483177 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 22633539 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20833135 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 24657443 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 25931349 | ||
| Pubmed | Mapping of ezrin dimerization using yeast two-hybrid screening. | 2.46e-05 | 2 | 173 | 2 | 9501018 | |
| Pubmed | Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. | 2.46e-05 | 2 | 173 | 2 | 12805220 | |
| Interaction | USP14 interactions | GBF1 LARS1 PSMC5 TUBB2B TUBB2A ARCN1 MYH14 AHNAK DOCK7 PATJ DDX39A SNRNP200 DYNC1H1 XRCC6 AHNAK2 RGPD5 | 3.26e-06 | 489 | 167 | 16 | int:USP14 |
| Interaction | ATG16L1 interactions | EZR RANBP2 MYCBP2 VPS13C KIAA0586 LARS1 LCP1 YES1 SNX29 ITPR2 SFXN1 USP5 PIK3C2A PIK3C3 CCSER2 MEPCE CSTF2 DIAPH3 PATJ DDX39A FHIP1A CWF19L1 XRCC6 CSTF2T KNL1 RGPD5 | 3.50e-06 | 1161 | 167 | 26 | int:ATG16L1 |
| Interaction | BAP1 interactions | EZR RANBP2 GBF1 PSAP MYCBP2 LARS1 PSMC5 RDX E2F1 COPG2 TUBB2B LCP1 TUBB2A ARCN1 SCAF4 TUBB6 STK11 USP5 FAT1 AHNAK DOCK7 CSTF2 ELF1 PATJ MAP3K7 SNRNP200 DYNC1H1 XRCC6 | 3.64e-06 | 1314 | 167 | 28 | int:BAP1 |
| Interaction | LRRC31 interactions | GBF1 DDX60 LRRC31 MYH14 MTOR AHNAK DOCK7 ANKRD30A SNRNP200 XRCC6 | 8.42e-06 | 205 | 167 | 10 | int:LRRC31 |
| Interaction | USP11 interactions | MYCBP2 LARS1 E2F1 TUBB2B LCP1 NDUFV2 SFXN1 TUBB6 STK11 PIK3C3 MYH14 MTOR DDX39A SNRNP200 DYNC1H1 XRCC6 | 1.11e-05 | 539 | 167 | 16 | int:USP11 |
| Interaction | KCNA3 interactions | EZR RANBP2 LARS1 DOCK10 PSMC5 RDX COPG2 ARCN1 TUBB6 AHNAK VPS13A DOCK7 KMT2A DIAPH3 PATJ DDX39A SNRNP200 DYNC1H1 XRCC6 EPB41L1 EPHA3 | 1.12e-05 | 871 | 167 | 21 | int:KCNA3 |
| Interaction | BRCA1 interactions | EZR RPGRIP1 GBF1 MAN2C1 PSAP POLE LARS1 PSMC5 RDX E2F1 PGR JAK2 TUBB6 EGR1 MYH14 MTOR FAM161A AHNAK CSTF2 DDX39A USH2A SNRNP200 DYNC1H1 XRCC6 TP53BP1 KNL1 | 1.28e-05 | 1249 | 167 | 26 | int:BRCA1 |
| Interaction | JSRP1 interactions | 2.44e-05 | 21 | 167 | 4 | int:JSRP1 | |
| Interaction | DUSP16 interactions | VPS13C POLE TUBB2B TUBB6 PIK3C2A SNRNP200 DYNC1H1 CSTF2T KNL1 RGPD5 | 2.95e-05 | 237 | 167 | 10 | int:DUSP16 |
| Interaction | AGR2 interactions | EZR MYCBP2 LARS1 COPG2 TUBB2A ARCN1 EPG5 DNAH1 SFXN1 KLHL38 TUBB6 USP5 MYH14 AHNAK KMT2A DDX39A MUC5AC SNRNP200 DYNC1H1 XRCC6 AHNAK2 | 3.16e-05 | 934 | 167 | 21 | int:AGR2 |
| Interaction | ERBB2 interactions | EZR PSAP ZNF280C RDX YES1 SH2B2 PTPRT JAK2 TUBB6 STK11 PIK3C2A PTPRR MEPCE DOCK7 EPHA1 EPHA3 | 3.27e-05 | 589 | 167 | 16 | int:ERBB2 |
| Interaction | RGPD8 interactions | 3.44e-05 | 74 | 167 | 6 | int:RGPD8 | |
| Interaction | CAPS interactions | 5.02e-05 | 25 | 167 | 4 | int:CAPS | |
| Interaction | ATOH1 interactions | 5.36e-05 | 80 | 167 | 6 | int:ATOH1 | |
| Interaction | ISG15 interactions | EZR ATP13A1 LARS1 TUBB6 USP5 AHNAK MEPCE TAGLN DDX39A MAP3K7 SNRNP200 DYNC1H1 XRCC6 AHNAK2 | 6.61e-05 | 494 | 167 | 14 | int:ISG15 |
| Interaction | TOP3B interactions | ATMIN TDRKH CRYBG2 GBF1 MYCBP2 ATP13A1 POLE EMID1 LARS1 YES1 SH2B2 PAIP1 ITPR2 JAK2 BMP8B FAT1 LRRC31 TMEM259 MTOR AHNAK DIAPH2 TAGLN DYNC1H1 XRCC6 TP53BP1 AHNAK2 TJP3 | 7.63e-05 | 1470 | 167 | 27 | int:TOP3B |
| GeneFamily | Dyneins, axonemal | 9.71e-10 | 17 | 122 | 6 | 536 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.14e-05 | 50 | 122 | 5 | 1293 | |
| GeneFamily | Cadherin related | 1.90e-04 | 17 | 122 | 3 | 24 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.65e-04 | 21 | 122 | 3 | 813 | |
| GeneFamily | Tubulins | 6.96e-04 | 26 | 122 | 3 | 778 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.23e-03 | 8 | 122 | 2 | 831 | |
| GeneFamily | DEAD-box helicases | 2.84e-03 | 42 | 122 | 3 | 499 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.90e-03 | 14 | 122 | 2 | 1095 | |
| GeneFamily | Myosin heavy chains | 4.48e-03 | 15 | 122 | 2 | 1098 | |
| GeneFamily | Fibronectin type III domain containing | 4.61e-03 | 160 | 122 | 5 | 555 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.36e-08 | 193 | 168 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-08 | 194 | 168 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-08 | 195 | 168 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-08 | 195 | 168 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-08 | 196 | 168 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.67e-08 | 198 | 168 | 9 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.27e-08 | 200 | 168 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.56e-07 | 168 | 168 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-07 | 171 | 168 | 8 | 8772d6349db24de47f089df2032a80345db7177f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 185 | 168 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 6.26e-07 | 189 | 168 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.52e-07 | 190 | 168 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-07 | 193 | 168 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-07 | 194 | 168 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.24e-07 | 196 | 168 | 8 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.24e-07 | 196 | 168 | 8 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 8.89e-07 | 198 | 168 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.89e-07 | 198 | 168 | 8 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.89e-07 | 198 | 168 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.24e-07 | 199 | 168 | 8 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.24e-07 | 199 | 168 | 8 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.24e-07 | 199 | 168 | 8 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-07 | 200 | 168 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-07 | 200 | 168 | 8 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-07 | 200 | 168 | 8 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Macroglial-Astrocyte|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 6ff22adb3007c3c9ef64a05c9dbc1d440bdaee1b | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-07 | 200 | 168 | 8 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.75e-06 | 151 | 168 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-06 | 170 | 168 | 7 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 170 | 168 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 170 | 168 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-06 | 174 | 168 | 7 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.21e-06 | 178 | 168 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.40e-06 | 179 | 168 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.03e-06 | 182 | 168 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-06 | 184 | 168 | 7 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 6.71e-06 | 185 | 168 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.95e-06 | 186 | 168 | 7 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.95e-06 | 186 | 168 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.95e-06 | 186 | 168 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 187 | 168 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.20e-06 | 187 | 168 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.45e-06 | 188 | 168 | 7 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.45e-06 | 188 | 168 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.45e-06 | 188 | 168 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.45e-06 | 188 | 168 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.71e-06 | 189 | 168 | 7 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 7.98e-06 | 190 | 168 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.26e-06 | 191 | 168 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.26e-06 | 191 | 168 | 7 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.26e-06 | 191 | 168 | 7 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 8.26e-06 | 191 | 168 | 7 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-06 | 192 | 168 | 7 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-06 | 192 | 168 | 7 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.55e-06 | 192 | 168 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.84e-06 | 193 | 168 | 7 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-06 | 193 | 168 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-06 | 194 | 168 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.14e-06 | 194 | 168 | 7 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.14e-06 | 194 | 168 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.46e-06 | 195 | 168 | 7 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | facs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 21cfcb751e548591fc8724a8329c294da6012e0f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-06 | 196 | 168 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 9.78e-06 | 196 | 168 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-05 | 197 | 168 | 7 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 197 | 168 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-05 | 197 | 168 | 7 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.01e-05 | 197 | 168 | 7 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-05 | 198 | 168 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 199 | 168 | 7 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 199 | 168 | 7 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 199 | 168 | 7 | b974b495cabbcc3934936cec846c0e2442a70ac3 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.08e-05 | 199 | 168 | 7 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 199 | 168 | 7 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 199 | 168 | 7 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-05 | 199 | 168 | 7 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-05 | 199 | 168 | 7 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-05 | 199 | 168 | 7 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Macroglial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | 42dc8ed66a021097e703eef2d756607396ca2f56 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-05 | 200 | 168 | 7 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.11e-05 | 200 | 168 | 7 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 200 | 168 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.11e-05 | 200 | 168 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 200 | 168 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-05 | 200 | 168 | 7 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.11e-05 | 200 | 168 | 7 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| Drug | tropone | 2.91e-06 | 31 | 167 | 5 | CID000010881 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 4.68e-06 | 34 | 167 | 5 | ctd:C569670 | |
| Disease | Colorectal Carcinoma | POLE PSMC5 TUBB2A PTPRT SFXN1 STK11 ABCG1 FAT1 VPS13A IGSF21 DNAH8 SNRNP200 TBX1 EPHA1 EPHA3 | 9.56e-06 | 702 | 164 | 15 | C0009402 |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.46e-05 | 27 | 164 | 4 | DOID:10584 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 1.97e-05 | 10 | 164 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 2.93e-05 | 32 | 164 | 4 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 2.93e-05 | 32 | 164 | 4 | C0149782 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 3.07e-05 | 2 | 164 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 3.07e-05 | 2 | 164 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 3.57e-05 | 12 | 164 | 3 | DOID:0050997 (implicated_via_orthology) | |
| Disease | cervical cancer | 3.75e-05 | 34 | 164 | 4 | C4048328 | |
| Disease | Malformations of Cortical Development | 5.87e-05 | 14 | 164 | 3 | C1955869 | |
| Disease | Cortical Dysplasia | 5.87e-05 | 14 | 164 | 3 | C0431380 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | EZR CYP19A1 AOX1 SULT1E1 JAK2 SERPINB10 EGR1 MYH14 KMT2A PATJ MAP3K7 TJP3 | 1.81e-04 | 616 | 164 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | EZR CYP19A1 AOX1 SULT1E1 JAK2 SERPINB10 EGR1 MYH14 KMT2A PATJ MAP3K7 TJP3 | 1.81e-04 | 616 | 164 | 12 | C0376358 |
| Disease | liver cancer (implicated_via_orthology) | 1.83e-04 | 4 | 164 | 2 | DOID:3571 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy, remission | 2.75e-04 | 23 | 164 | 3 | EFO_0009785, MONDO_0002321 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.89e-04 | 57 | 164 | 4 | EFO_0022284 | |
| Disease | Retinitis Pigmentosa | 2.94e-04 | 104 | 164 | 5 | C0035334 | |
| Disease | free cholesterol in very large VLDL measurement | 3.75e-04 | 61 | 164 | 4 | EFO_0022274 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 4.24e-04 | 63 | 164 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 4.24e-04 | 63 | 164 | 4 | EFO_0022239 | |
| Disease | PR interval | 4.75e-04 | 495 | 164 | 10 | EFO_0004462 | |
| Disease | Carcinoma, Granular Cell | 4.87e-04 | 116 | 164 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.87e-04 | 116 | 164 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.87e-04 | 116 | 164 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.87e-04 | 116 | 164 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.87e-04 | 116 | 164 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 4.87e-04 | 116 | 164 | 5 | C0001418 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.99e-04 | 28 | 164 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | total lipids in small VLDL | 5.37e-04 | 67 | 164 | 4 | EFO_0022148 | |
| Disease | free cholesterol in large VLDL measurement | 5.68e-04 | 68 | 164 | 4 | EFO_0022265 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 6.13e-04 | 30 | 164 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 6.13e-04 | 30 | 164 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 8.14e-04 | 33 | 164 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 8.23e-04 | 75 | 164 | 4 | EFO_0022287 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | myelofibrosis (is_implicated_in) | 8.41e-04 | 8 | 164 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | endometrial cancer (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | Uterine Cervical Neoplasm | 9.68e-04 | 35 | 164 | 3 | C0007873 | |
| Disease | Glioblastoma | 9.99e-04 | 79 | 164 | 4 | C0017636 | |
| Disease | endometrial cancer (is_implicated_in) | 1.05e-03 | 36 | 164 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Disorder of eye | 1.23e-03 | 212 | 164 | 6 | C0015397 | |
| Disease | nitric oxide exhalation measurement | 1.23e-03 | 38 | 164 | 3 | EFO_0005536 | |
| Disease | Giant Cell Glioblastoma | 1.26e-03 | 84 | 164 | 4 | C0334588 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 1.34e-03 | 10 | 164 | 2 | EFO_0800333 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.37e-03 | 86 | 164 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | Mesothelioma | 1.54e-03 | 41 | 164 | 3 | C0025500 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.54e-03 | 41 | 164 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | osteosarcoma (is_marker_for) | 1.63e-03 | 11 | 164 | 2 | DOID:3347 (is_marker_for) | |
| Disease | high grade glioma (is_marker_for) | 1.65e-03 | 42 | 164 | 3 | DOID:3070 (is_marker_for) | |
| Disease | triglycerides in large LDL measurement | 1.77e-03 | 43 | 164 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.77e-03 | 43 | 164 | 3 | EFO_0022278 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.77e-03 | 43 | 164 | 3 | EFO_0022290 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.83e-03 | 156 | 164 | 5 | C0007131 | |
| Disease | Clear Cell Meningioma | 1.95e-03 | 12 | 164 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.95e-03 | 12 | 164 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.95e-03 | 12 | 164 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.95e-03 | 12 | 164 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.95e-03 | 12 | 164 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.95e-03 | 12 | 164 | 2 | C1527197 | |
| Disease | Dental enamel hypoplasia | 1.95e-03 | 12 | 164 | 2 | EFO_1001304 | |
| Disease | Meningiomas, Multiple | 1.95e-03 | 12 | 164 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.95e-03 | 12 | 164 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.95e-03 | 12 | 164 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.95e-03 | 12 | 164 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.95e-03 | 12 | 164 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 1.95e-03 | 12 | 164 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.95e-03 | 12 | 164 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 1.95e-03 | 12 | 164 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.95e-03 | 12 | 164 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.95e-03 | 12 | 164 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 1.95e-03 | 12 | 164 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.95e-03 | 12 | 164 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.95e-03 | 12 | 164 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.95e-03 | 12 | 164 | 2 | C1384406 | |
| Disease | saturated fatty acids measurement | 2.02e-03 | 45 | 164 | 3 | EFO_0022304 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 2.30e-03 | 13 | 164 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.57e-03 | 49 | 164 | 3 | EFO_0022256 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 2.67e-03 | 14 | 164 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | phospholipids in very small VLDL measurement | 2.89e-03 | 51 | 164 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.89e-03 | 51 | 164 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.89e-03 | 51 | 164 | 3 | EFO_0022242 | |
| Disease | thrombosis (is_implicated_in) | 3.07e-03 | 15 | 164 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | triglycerides in HDL measurement | 3.22e-03 | 53 | 164 | 3 | EFO_0022317 | |
| Disease | total lipids in medium VLDL | 3.40e-03 | 54 | 164 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 3.40e-03 | 54 | 164 | 3 | EFO_0022321 | |
| Disease | Glioblastoma Multiforme | 3.47e-03 | 111 | 164 | 4 | C1621958 | |
| Disease | endometriosis (biomarker_via_orthology) | 3.50e-03 | 16 | 164 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | triglycerides in medium VLDL measurement | 3.58e-03 | 55 | 164 | 3 | EFO_0022155 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDPLVSLMMVEKVPD | 131 | P62195 | |
| LPETTRPQEMMKIFA | 601 | Q9HCE0 | |
| KPIMIITEFMENGAL | 696 | P21709 | |
| KQTLFMMDDPVPVHT | 371 | P55345 | |
| PMAAFLIQTKDNPMK | 686 | Q96JP9 | |
| IPSSQPMTVLKENVM | 471 | P32519 | |
| PAKPEEEGMMINISI | 31 | O42043 | |
| AKTMADVPFQIMFPV | 501 | P45844 | |
| PVCRKFMQDPMEVFV | 236 | O00148 | |
| MLTGESVPQMKEPIE | 351 | Q9HD20 | |
| MVPSDPSIEEMRKVV | 421 | Q8NER5 | |
| ALELMDMQTFKAEPP | 741 | Q9BXX3 | |
| LELMDMQTFKAEPPE | 861 | Q9BXX3 | |
| TLPMQAPELAVKEME | 116 | Q8TDX5 | |
| MHFKAPNISMPDVDL | 2446 | Q09666 | |
| EMNIKAPKISMPDFD | 2571 | Q09666 | |
| MDVSLPKVEGDMQVP | 3891 | Q09666 | |
| EMNIKAPKISMPDFD | 4451 | Q09666 | |
| FSEEVMPQPVLKAMR | 91 | Q8N1D0 | |
| LMETMKQPFLPGEVK | 526 | P21127 | |
| ARAIDPKQPNMMTEI | 261 | O60879 | |
| EPEQFGVVMSSVKML | 776 | O60879 | |
| AVDPRHPNMMTDVVK | 276 | Q9NSV4 | |
| AVASLPPEQMFELMK | 131 | P33240 | |
| VPTIQNSMKPFKDMD | 301 | O75907 | |
| EGFLEAPKMEMSQAP | 741 | A6H8M9 | |
| TAKDPVVADLMKNPM | 176 | Q8IUH2 | |
| LIFPPELMIMAEKQS | 216 | Q06278 | |
| NPPIDEKNATMPVTM | 431 | Q9UKX7 | |
| PRVFSSVMKPENMIV | 221 | Q7Z5L2 | |
| TISVPQFPMDLNSKM | 256 | Q09MP3 | |
| PVPLESVKEMLNSVM | 736 | P49792 | |
| VLAKIVPMEQSYPMV | 106 | Q96AH8 | |
| PVPLESVKQMLNSVM | 736 | Q99666 | |
| PVPLESVKQMLNSVM | 736 | O14715 | |
| GVAQMKDMVTELFDP | 36 | Q9BXV9 | |
| IEKSKSPPAEFMRMI | 1051 | O60674 | |
| AEEVTMSPAIAIMQP | 1906 | Q14571 | |
| EMLKFQDATAVVPPM | 496 | Q9UJ83 | |
| MPKPINVRVTTMDAE | 1 | P35241 | |
| PNTFFEPRKEVTMTM | 191 | Q8N7Z5 | |
| AEVIVPITVMNKAMP | 2166 | Q14517 | |
| TPDMPQFEPVKTETM | 686 | Q9H4G0 | |
| TSAVMPKMLEGFLQE | 76 | Q9GZK7 | |
| SQMLVTSKMAAPEAP | 171 | Q96JG8 | |
| MIEMAAEKEPFLVPA | 1 | Q7L2J0 | |
| MPTKAVDPEAFMNIS | 36 | Q5VYY2 | |
| SEFSMQEPMVPAKLG | 786 | O75335 | |
| ASDPFAFMVVVKPMN | 421 | Q5SZK8 | |
| SVKFPEPDAALMIMD | 446 | Q9C098 | |
| SPENMITMFPLLVEK | 1106 | Q8IY21 | |
| FSIVPMKLMDAAELV | 241 | Q69YN2 | |
| AEMQLMSPLQISDPF | 6 | P18146 | |
| IQRMNPPKFSKAEDM | 96 | Q7Z406 | |
| PEDLVEVNPKMVMTV | 601 | P13796 | |
| AVPLKVTMVNADPMG | 1116 | O00443 | |
| EVPSVFVNLMTPKMK | 656 | Q96JB1 | |
| AMPTDKMLTPNGFEA | 206 | Q9UBC0 | |
| ADMKEMVALLPFLPD | 101 | Q6UY01 | |
| PSQRPSMEEIVKIMT | 271 | O43318 | |
| NVQIAAAPTPEKEMM | 531 | Q8NG31 | |
| TPMEFGNLQKMDDPT | 231 | P98088 | |
| LPLKFPDAETDQIMM | 281 | Q07864 | |
| KMINLMRPGVFADIE | 2256 | P23471 | |
| MEKANETSPVMGFVL | 1 | Q9NQN1 | |
| PLEFTFQKRELPQMM | 671 | Q96FC9 | |
| EDNTVTIPLMIMKPD | 1111 | P17301 | |
| SAMAKPQVVVAPVLM | 111 | Q9H074 | |
| ITAFGVQKPLMDMAP | 136 | Q92982 | |
| EFMEIPMNFVDPKEI | 396 | Q15256 | |
| EKPMLDQAVPTGSFM | 61 | O14522 | |
| PEMMSEVIAAQLPKI | 906 | P06401 | |
| PMFTEKEMILKIPEN | 131 | Q9NRJ7 | |
| AQDPPMEKALSMFSD | 36 | Q9UBY9 | |
| MPFFQAQKMFVDVPE | 641 | Q9H7U1 | |
| NLKALFRPVAMMVPD | 1696 | Q9P2D7 | |
| VALVKLPVMQFSVMP | 301 | O43313 | |
| DNLKALFRPFAMMVP | 1586 | Q9C0G6 | |
| FTKPPDLVMTVMEAI | 2801 | Q9C0G6 | |
| MSDMTPAALTKDPIQ | 946 | Q05DH4 | |
| PALSMPMQAEVTLVA | 326 | Q96ID5 | |
| MVMVIKAPPETQLQA | 261 | Q01094 | |
| FIPVKPFNMMAQTEP | 636 | Q96BY6 | |
| THQDPADPKMLQMVL | 2011 | Q96N67 | |
| PDETKNMLEMIFTPR | 481 | P11511 | |
| PAKPEEEGMMINISI | 31 | P61566 | |
| PAKPEEEGMMINISI | 31 | P61567 | |
| KQGPLFVEDIMTMVL | 36 | A8MTZ0 | |
| LVSGAQMEAPQKEMF | 41 | Q8N1P7 | |
| KALSTPPNTAELMEM | 596 | Q8WXX0 | |
| GKRMVVFVDDVNMPA | 2036 | Q8WXX0 | |
| VIKMPMVDPEAQAPT | 301 | P11229 | |
| MKSIPLAMAPVFEQK | 576 | Q9UBF2 | |
| VKNLAMFPDTVPMDS | 206 | P29320 | |
| PDNLKSLFRPVAMMV | 1251 | Q0VDD8 | |
| PAKPEEEGMMINISI | 141 | P61565 | |
| PAKPEEEGMMINISI | 31 | Q9HDB8 | |
| MIAAPDPEKMFQLSR | 161 | Q9NTJ4 | |
| EMNMAIAFPAAPLLT | 341 | Q4ZIN3 | |
| VKVSPDMAIFITMNP | 2006 | Q14204 | |
| LFKQTVIQDPMPMEP | 1716 | Q92538 | |
| PSDIMDFVLKNTPSM | 2846 | Q03164 | |
| KMLAAPINPSDINMI | 76 | Q9BV79 | |
| AVASLPPEQMFELMK | 131 | Q9H0L4 | |
| EAKMTMLTVIEQPVP | 151 | Q96A84 | |
| MPKPINVRVTTMDAE | 1 | P15311 | |
| ITVPEPFQMMIREQK | 236 | Q3B820 | |
| SKMLPVDEFLPVMFD | 516 | Q8NBJ5 | |
| QSLVHLMMPDAVPKA | 351 | P34820 | |
| QPLMPGETFSMDSIK | 656 | Q9Y238 | |
| PENLKSMFRPIAMVV | 1916 | Q9P225 | |
| AFNQELFSLMDMKPP | 6 | O95104 | |
| DMGKMLQFVLPVATQ | 46 | Q99622 | |
| APPINMESVHMKIEE | 266 | P48444 | |
| EMAEMAEPITKPSAL | 61 | A6NHN0 | |
| MPADIMEKNSSSPVA | 1 | Q14469 | |
| PSNDPVVMEMASKAI | 116 | P42345 | |
| MLTSDPPKLNAFIMD | 731 | O60391 | |
| GIMVEDSPMLKSPFA | 466 | Q5VT97 | |
| SRMFVKTPEAAPMDL | 3856 | O75445 | |
| SMPSSPMINELVEEK | 1566 | Q2M3C7 | |
| HVPFKDMPATQMLLE | 276 | Q7RTN6 | |
| IMASNTMQVEEPPKS | 226 | Q96KN7 | |
| MNKVIQMVPEFAASP | 746 | Q8TEQ0 | |
| MAIPPFIMNTLEKKA | 241 | Q9H9B4 | |
| DVMGNKTLPMTDFQP | 811 | A0AVI2 | |
| NIGVEMMKNFTPIEV | 291 | Q96DL1 | |
| MMKNFTPIEVIPCNK | 296 | Q96DL1 | |
| PFVAMIKENLEKMGP | 991 | Q9P2J5 | |
| IKSTFPEEMQRFMPP | 621 | P58743 | |
| MPTESDFLMQVDGKP | 121 | O14793 | |
| ELVKVPDPQMSMENL | 251 | Q8NEB9 | |
| IFAAEMVLKLIAMDP | 786 | Q15858 | |
| AFILGDVPMMAKIAE | 196 | Q8WV41 | |
| DRIMNTFSVMPSPKV | 161 | Q13885 | |
| PESVFMELVLGKMNP | 111 | Q9UJQ7 | |
| NPPKFDRIEDMAMLT | 81 | P11055 | |
| NVFEEPESNMKSMPP | 3441 | O75592 | |
| FPSMEQLAAMLPSVV | 86 | Q9ULP0 | |
| MQEMLDSVPEKRFPV | 136 | Q15831 | |
| ENPPSMVFKQMEQVA | 81 | Q01995 | |
| PFQLSEGKNVTVEMM | 201 | Q96P15 | |
| PLKEMPAVQLDTQHM | 21 | Q5W111 | |
| FKEVPMMVPADVFVG | 261 | A8MXE2 | |
| VDVSAPKMEADMSIP | 4486 | Q8IVF2 | |
| TAKNAFPTLSPMVVM | 81 | Q9C0C6 | |
| FPTLSPMVVMKNVLV | 86 | Q9C0C6 | |
| MGIKNFMPALEETPF | 256 | Q15583 | |
| MPFTEKIMATPEQVG | 446 | P12956 | |
| ENAAKVLMAPPSMVN | 16 | Q9C0E2 | |
| MAEAALVITPQIPMV | 1 | Q6P9A3 | |
| PTTELVPKGEMIKMN | 1711 | Q96RL7 | |
| MDSAPKPFTDVSIVM | 2676 | Q96RL7 | |
| KSEAQAIPEMPMFEI | 281 | Q9Y2W6 | |
| TLPDEIMNQKLSPFM | 241 | P49888 | |
| DRIMNTFSVMPSPKV | 161 | Q9BUF5 | |
| MKENFVMESLPSVPS | 946 | Q8NI35 | |
| DRIMNTFSVMPSPKV | 161 | Q9BVA1 | |
| ELHLKMMAPQEAVPA | 96 | Q6ZN55 | |
| MDAVSQVPMEVVLPK | 1 | Q9BZL3 | |
| PNMTLKAMITDPEVV | 2101 | Q709C8 | |
| EVNFDKDPMEMRLPI | 3161 | Q709C8 | |
| TTMPLEMPEKDNTFV | 261 | O14492 | |
| DMPFSPKASVAAMEA | 261 | Q12888 | |
| MIFMQILEPQEVPSF | 1 | Q6UXP9 | |
| CDEVKEMPMQTLVPA | 271 | P07602 | |
| QLPIESQMVSKLPDM | 886 | O75643 | |
| PVADIAMQKLTAEMP | 626 | O95049 | |
| MALTQGPLKFMDVAI | 1 | Q3MIS6 | |
| MQAVVPLNKMTAISP | 1 | Q8TF39 | |
| KIPMDIMEQQPFLSD | 1046 | Q9Y6R1 | |
| PTPITEMEISVKRQM | 491 | Q9NS98 | |
| PFQPKNISKMAELFM | 6 | Q8ND82 | |
| PTFQVKLFGMDPMAD | 141 | O43435 | |
| VPMFADQPDNIAHMK | 391 | P0DTE4 | |
| AVMPEPSMTKILDSF | 231 | P18583 | |
| PFRINETTSKPVQMM | 206 | P48595 | |
| IMQLPVPMDAALNKE | 486 | P45974 | |
| KGDDMPAIMLVNTPT | 1086 | Q9BVV6 | |
| TLKPGTMMPEAFLQE | 306 | P07947 | |
| AKSVIGTPEFMAPEM | 306 | Q9BYP7 | |
| PVMEAASMLQFPKLF | 106 | Q2WGJ6 | |
| LTVNEMPSFLKTPMD | 596 | O94898 | |
| VMETPAFPTVMKLLE | 346 | Q6PIF6 | |
| APEKDMVSMAVLPLA | 1621 | Q6PIF6 | |
| SAMNKVAEVLQVPPM | 96 | P19404 |